Frank Bruchertseifer
European Commission(BE)Applied Materials (United Kingdom)(GB)Joint Research Centre(DE)Istanbul Technical University(TR)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Medical Imaging Techniques and Applications, Prostate Cancer Treatment and Research, Monoclonal and Polyclonal Antibodies Research, Peptidase Inhibition and Analysis
Most-Cited Works
- → 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer(2016)1,060 cited
- → Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding(2017)487 cited
- → Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control(2018)418 cited
- → 213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience(2014)391 cited
- → An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth(2018)350 cited
- → 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study(2018)